Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2023-11-20 | 2023-09 | 0 | N/A | N/A | N/A |
2023-05-10 | 2023-03 | 0 | N/A | N/A | N/A |
2023-04-17 | 2022-12 | 0 | N/A | N/A | N/A |
2022-11-21 | 2022-09 | -4.8 | N/A | N/A | N/A |
2022-11-10 | 2022-06 | 0 | N/A | N/A | N/A |
2022-05-23 | 2022-03 | -7.21 | N/A | N/A | N/A |
Split | Date |
---|---|
1 : 30 | 2023-05-17 |
1 : 10 | 2020-09-08 |
1 : 30 | 2018-07-10 |
1 : 3 | 2016-09-29 |
-
Just now fucking hearing another offering immenant
-
Finally got out lost half my money but I’m done letting this company rob me
-
The piece of shit ceo makes the split decision months before needed then waits for stock to drop 50% he gotta go if it’s ever gonna work he blows at his job
-
We should all just take the hit this piece shit ceo deserves to lose this company instead stealing everyone money every few months scumbag
-
You didnt get it? They do reverse split that high so every day will be -.20$ and 11th day down under 1$
-
Is there anything that can be done or is the ceo just totally the worst ceo milling this company as long as they can do r/s till no more money
-
Fucking crooks
-
Authorization for the reverse stock split was approved by the Companys stockholders at Biocepts 2020 Annual Meeting of Stockholders. The objective of the reverse stock split is to increase the market price for the Companys common stock to, among things, enable the Company to regain compliance with the $1.00 minimum bid price requirement under applicable Nasdaq Listing Rules.
As a result of the reverse stock split, each ten pre-split shares of common stock outstanding will automatically combine and convert to one issued and outstanding share of common stock without any action on the part of the stockholder. No fractional shares of common stock will be issued to any shareholders in connection with the reverse stock split. Holders of record will receive a cash payment in lieu of fractional shares.
Stockholders of record will receive information regarding their share ownership following the reverse stock split from the Company's transfer agent, Continental Stock Transfer & Trust. Continental Stock Transfer & Trust can be reached at (212) 509-4000.
For additional information regarding the reverse stock split, please refer to Biocepts Current Report on Form 8-K, filed with the Securities and Exchange Commission on September 4, 2020.
-
It will down more after the split
-
This company doing split every 2 years lol it heading down under 50 cent again after
-
Fucking crooks
-
This drop is all because of the ceo announcement of rs which could have waited months
-
Nobody is trading this stock
-
The price didn’t even move a penny
-
This company will never make it they been around for decade still can’t make it fire the ceo
-
I sold everything fuck this piece of poop
-
Why not moving??? This stock has concrete holding it down
-
Finally after all this roller coaster shit MERGER IMMINENT!!!!!!!!! I fucking knew it !!!!$$$$$$$$$$$$$$
-
Fucking ceo put out something this company is gonna go bust dumb ass
-
Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics
businesswire.com • -
Biocept to Participate in the H.C. Wainwright Global Investment Conference
businesswire.com • -
Biocept, Inc. (BIOC) Business Update Conference Call (Transcript)
seekingalpha.com • -
Biocept to Hold Business Update Conference Call on August 30, 2023
businesswire.com • -
7 F-Rated Biotech Stocks You Shouldn't Touch With a 10-Foot Pole
investorplace.com • -
Biocept Reports Second Quarter 2023 Financial Results
businesswire.com • -
Biocept CNSide assay takes the spotlight at 2023 SNO/ASCO CNS Cancer Conference
proactiveinvestors.com • -
Biocept Announces the Passing of Board Chair M. Faye Wilson
businesswire.com • -
Biocept appoints Antonino Morales as president and chief executive officer
proactiveinvestors.com • -
Biocept Names Antonino Morales as President and Chief Executive Officer
businesswire.com • -
Why Is Biocept (BIOC) Stock Down 42% Today?
investorplace.com • -
Biocept Announces Pricing of $5.0 Million Underwritten Public Offering
businesswire.com • -
Biocept shares to commence trading on split-adjusted basis
proactiveinvestors.com • -
Biocept Announces One-for-Thirty Reverse Stock Split
businesswire.com • -
Biocept Announces One-for-Thirty Reverse Stock Split
businesswire.com •